EyeBio

Healthcare & Life Sciences

Recent Finacing

Series A

Recent Raise

$65M

EyeBio is a clinical-stage ophthalmology biotechnology company focused on developing therapies for sight-threatening eye diseases and has expanded its Series A funding to $130 million.